Ajanta Pharma receives US FDA Form 483 with 5 observations for Paithan facility 22/04/2026 / Material Events / Regulatory Inspection Outcome Ajanta Pharma receives US FDA Form 483 with 5 observations for Paithan facility Read Post ยป
